Replies to post #2196 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

That’s the Merrimack phase-2a study in RA that was started in 2004 and completed in 2005:

http://www.merrimackpharma.com/newsEvents/2004/25Aug04RAphaseIIA.pdf

The Merrimack RA study on which we are awaiting results is the much larger phase-2b study that started in 2005 and finished in mid 2006. Regards, Dew